Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells

被引:0
|
作者
Masahiro Murakami
Shogo Kobayashi
Shigeru Marubashi
Yoshito Tomimaru
Takehiro Noda
Hiroshi Wada
Hidetoshi Eguchi
Yutaka Takeda
Masahiro Tanemura
Koji Umeshita
Yuichiro Doki
Masaki Mori
Hiroaki Nagano
机构
[1] Osaka University,Department of Surgery, Graduate School of Medicine
来源
关键词
Vascular Endothelial Growth Factor; Sorafenib; HuH7 Cell; Vascular Endothelial Growth Factor Signaling; Portal Vein Tumor Thrombus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:589 / 596
页数:7
相关论文
共 50 条
  • [31] Combined intraarterial 5-fluorouracil and intramuscular interferon-alpha therapy for advanced hepatocellular carcinoma
    Ohmoto, K
    Iguchi, Y
    Mimura, N
    Tsuduki, M
    Shimabara, M
    Kuboki, M
    Yamamoto, S
    HEPATO-GASTROENTEROLOGY, 2003, 50 (54) : 1780 - 1782
  • [32] Anti-angiogenic effects of combination therapy of interferon-alpha and 5-fluorouracil in the treatment for advanced hepatocellular carcinoma
    Wada, Hiroshi
    Nagano, Hiroaki
    Yamamoto, Hirofumi
    Ota, Hideo
    Nakamura, Masato
    Damdinsuren, Bazarragchaa
    Noda, Takehiro
    Marubashi, Shigeru
    Miyamoto, Atsushi
    Takeda, Yutaka
    Umeshita, Koji
    Dono, Keizo
    Monden, Morito
    HEPATOLOGY, 2006, 44 (04) : 623A - 623A
  • [33] Systemic Combined Chemotherapy with Low Dose of 5-Fluorouracil, Cisplatin, and Interferon-α for Advanced Hepatocellular Carcinoma: A Pilot Study
    Yasuji Komorizono
    Kazunori Kohara
    Makoto Oketani
    Masahiko Maeda
    Toshihiko Shibathou
    Shuhou Shigenobu
    Yasusi Hiramine
    Naruhiro Yamasaki
    Takushi Arima
    Ishibashi Kazuaki
    Terukatsu Arima
    Digestive Diseases and Sciences, 2003, 48 : 877 - 881
  • [34] Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism
    Xu, Huanli
    Yang, Tao
    Liu, Xiaohui
    Tian, Ye
    Chen, Xiaoliang
    Yuan, Ru
    Su, Shuonan
    Lin, Xiukun
    Du, Guanhua
    LIFE SCIENCES, 2016, 144 : 138 - 147
  • [35] Systemic combined chemotherapy with low dose of 5-fluorouracil, cisplatin, and interferon-α for advanced hepatocellular carcinoma -: A pilot study
    Komorizono, Y
    Kohara, K
    Oketani, M
    Maeda, M
    Shibathou, T
    Shigenobu, S
    Hiramine, Y
    Yamasaki, N
    Arima, T
    Kazuaki, I
    Arima, T
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (05) : 877 - 881
  • [36] Comparative antitumor activity of 5-fluorouracil and 5′-deoxy-5-fluorouridine in combination with interferon-α in renal cell carcinoma cell lines
    Ikemoto, S
    Sugimura, K
    Yoshida, N
    Kuratsukuri, K
    Wada, S
    Nakatani, T
    UROLOGIA INTERNATIONALIS, 2004, 73 (04) : 348 - 353
  • [37] Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma
    Yashiro, Masakazu
    Shinto, Osamu
    Nakamura, Kazunori
    Tendo, Masashige
    Matsuoka, Tasuku
    Matsuzaki, Taro
    Kaizaki, Ryoji
    Miwa, Atsushi
    Hirakawa, Kosei
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (04) : 1004 - 1016
  • [38] The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma
    Wang, Fan
    Dai, Weiqi
    Wang, Yugang
    Shen, Miao
    Chen, Kan
    Cheng, Ping
    Zhang, Yan
    Wang, Chengfen
    Li, Jingjing
    Zheng, Yuanyuan
    Lu, Jie
    Yang, Jing
    Zhu, Rong
    Zhang, Huawei
    Zhou, Yingqun
    Xu, Ling
    Guo, Chuanyong
    PLOS ONE, 2014, 9 (05):
  • [39] A comparison of the antitumor effects of interferon-α and β on human hepatocellular carcinoma cell lines
    Murata, M
    Nabeshima, S
    Kikuchi, K
    Yamaji, K
    Furusyo, N
    Hayashi, J
    CYTOKINE, 2006, 33 (03) : 121 - 128
  • [40] Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584
    Liu, YQ
    Poon, RT
    Li, QY
    Kok, TW
    Lau, C
    Fan, ST
    CANCER RESEARCH, 2005, 65 (09) : 3691 - 3699